Berenberg upgrades Eli Lilly to Buy after obesity-drug demand surge
Berenberg upgraded Eli Lilly to Buy from Hold, citing accelerating obesity-drug demand that could lead to results above the company’s ambitious 2026 outlook. Analyst Kerry Holford also raised her price target.
Eli Lilly NYSE:LLY won a fresh Wall Street endorsement Tuesday as Berenberg upgraded the pharmaceutical giant to Buy from Hold, saying accelerating obesity-drug demand could lift results above the company’s already ambitious 2026 outlook. Analyst Kerry Holford also raised her price target to…